LMWE:F:F-Lyxor FTSE EPRA/NAREIT Global Developed UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 37.555

Change

+0.30 (+0.81)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.21 (-0.77%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.56 (-1.08%)

USD 115.04B
FRCJ:F UBS MSCI Japan Socially Respon..

-0.21 (-0.97%)

USD 83.57B
SXR8:F iShares Core S&P 500 UCITS ETF..

+4.46 (+0.89%)

USD 80.45B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.36 (-0.65%)

USD 76.57B
EUNL:F iShares Core MSCI World UCITS ..

+0.38 (+0.42%)

USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.85 (-0.36%)

USD 58.19B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.11 (-0.69%)

USD 56.18B
VUSA:F Vanguard Funds Public Limited ..

+0.46 (+0.50%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.73 (+0.81%)

USD 49.95B

ETFs Containing LMWE:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.95% 15% F 36% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.95% 13% F 34% F
Trailing 12 Months  
Capital Gain -1.05% 28% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.05% 26% F 44% F
Trailing 5 Years  
Capital Gain -19.19% 7% C- 31% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -19.19% 7% C- 21% F
Average Annual (5 Year Horizon)  
Capital Gain -2.82% 27% F 38% F
Dividend Return -2.82% 26% F 35% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 19.06% 23% F 59% D-
Risk Adjusted Return -14.82% 36% F 38% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.